← FDA Drug Approvals (Drugs@FDA)

SITAGLIPTIN PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2026-01-14

Drug application

FDA Application #

ANDA202387

Application type

Abbreviated New Drug Application (Generic)

Brand name

SITAGLIPTIN PHOSPHATE

Generic name

SITAGLIPTIN PHOSPHATE

Active ingredients

SITAGLIPTIN PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2026-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown